Fever-Tree sees growth in US accelerating

Fever-Tree has kicked off the year in good shape, telling shareholders it remains confident of meeting full-year expectations and sweetening the news with a fresh £30m addition to its share buyback.

In a statement ahead of today’s AGM, the premium mixer maker said it had made a solid start and continued to push on with its strategic priorities.

Chief among them is the US, where the tie-up with Molson Coors is gathering pace. The partnership has moved past its initial transition phase and is now winning new accounts and building distribution, aided by the brand’s first national US marketing campaign, which rolled out across TV, digital, and e-commerce in April alongside a nationwide sampling push.

Closer to home, Fever-Tree is leaning harder into its drink-it-any-way message. A new UK campaign, positioning the brand as both a mixer and a premium soft drink in its own right, also launched in April.

Australia remains a bright spot, with the premium soft drinks range driving momentum and a new Lemon, Lime & Bitters launched in partnership with Angostura.

Tim Warrillow, CEO of Fever-Tree, said: “We have continued to make good progress against our strategic priorities so far this year. Fever-Tree is well placed to drive long-term growth across our markets as both a premium mixer and soft drink brand and this year we are significantly increasing marketing investment and innovating to support our growth ambitions.

Bellway maintains guidance despite softer market

Bellway has reassured investors that it remains on track to hit its full-year profit target, even as customer demand has softened in recent weeks due to the impact of the Middle East war.

It wouldn’t have been a surprise if Bellway had cut its guidance, so reaffirming its volume output guidance of between 9,300 and 9,500 homes for the year should go a long way with investors.

In a trading update covering the period from 1 February to 29 May, the housebuilder said it expects FY26 underlying operating profit to land within its previously guided range of £320m to £330m.

They said Spring trading started well, with a marked improvement on the autumn, but a rise in mortgage rates took some of the wind out of the sails through April and May.

Chief executive Jason Honeyman was relatively upbeat, noting that the business “continues to perform robustly in an increasingly challenging market.” He pointed to the group’s forward order book as a key source of support.

Private reservations slipped 6.2% to an average of 151 a week, down from 161 a year earlier. The forward order book stood at 5,345 homes worth £1,570m at the end of May, lower than the 5,759 homes and £1,650m booked twelve months ago. Encouragingly, cancellations stayed low at 10%, and reservation rates remain above their first-half levels.

The group is on course to open more than 40 new outlets in the second half, with another strong programme lined up for FY27. Land buying has been disciplined but active, with 6,744 plots contracted since August, including a sizeable 1,900-plot anchor site in Dunfermline that will feed both Scottish divisions. The strategic land bank now sits at around 47,000 plots.

AIM movers: Beeks Financial contract win and Audioboom ends strategic review

2

Corporate finance business Marechale Capital (LON: MAC) has obtained FCA approval for the acquisition of Stanford Capital Partners. This is one of the three acquisitions announced last week that will scale up the business. The share price jumped a further 22.55 to 5.45p and it is 173% higher since the end of May.  

Beeks Financial Cloud (LON: BKS) has signed a five-year contract worth £3.6m with a Tier 1 global bank for the deployment of AI-based trading analysis and monitoring tool Market Edge Intelligence software in one part of its business. This will help to underpin expectations for 2025-26. This helped the share price to rebound 17.9% to 191.5p.

Oriole Resources (LON: ORR) has announced further results from drilling at 50%-owned Mbe orogenic gold project in Cameroon. Gold is over significant widths in the two latest drill holes. An updated mineral resource estimate is expected in early third quarter 2026. The share price improved 11.7% to 0.335p.

Jangada Mines (LON: JAN) has started phase 2 drilling at the Molly gold project in Brazil. There will be ten holes totalling around 1,100 metres. This will refine geological models. The share price rose 6.82% to 1.175p.

FALLERS

Genetic testing developer GENinCODE (LON: GENI) reported 14% growth in 2025 revenues to £3.1m, but investment in preparation of growth in the US and other markets meant that the loss increased. There was a £4.12m cash outflow from operating activities during the year. Earlier this year, £4.3m net was raised at 1p/share, so there is enough cash to take the business into 2027. This year the new manufacturing and distribution deal with Thermo Fisher will start to make a contribution and an FDA submission for the CARDIO inCode-Score test assessing coronary genetic risk is expected in the third quarter. If things go to plan approval could be received by the end of 2026. Updated guidelines for this type of test were announced in March, and they should provide additional momentum for sales. This year Spain will continue to be the main generator of revenues, but GENinCODE is laying the foundations for additional growth in other markets next year. The share price dipped 17.4% to 0.95p.

Podcast platform operator Audioboom (LON: BOOM) has concluded its strategic review. There were three potential bidders, but they were deemed to be undervaluing the business. First quarter revenues were a record and a 2026 pre-tax profit of $6.5m is forecast. The share price declined 15.2% to 475p.

Capital machinery supplier Mpac (LON: MPAC) is selling its subsidiary Lambert and trading remains tough. Lambert produced specialist packaging lines and differed from the rest of the business which supplies more standardised capital equipment. Lambert lost money last year, but it is expected to return to profit in 2026. Italy-based Mech.i. Tronic is paying an initial £16m for Lambert with up to £4m more depending on performance in 2026. This deal is part of the reason behind a sharp cut in the 2026 pre-tax profit forecast, but there are also tough trading conditions putting pressure on margins.  Panmure Liberum has cut its pre-tax profit forecast from £15m to £8.5m. Net debt should be reduced to £30.8m by the end of the year. The share price slid 11.4% to 232.5p.

Great Western Mining Corporation (LON: GWMO) shares will start trading on the US OTCQB market today and they should be attractive to US investors because of the mining assets in Nevada. The share price fell 10.3% to 3.9p.

Why Alternative Building Materials Struggle to Reach Mainstream Construction 

The gap between material innovation and market adoption 

The construction industry is under increasing pressure to reconsider the materials it uses, driven by regulation, procurement standards and rising scrutiny of performance across the full lifecycle. With the buildings and construction sector accounting for approximately 35 to 40 per cent of global carbon emissions, the need for practical and scalable material innovation is becoming increasingly urgent. 

Recent industry analysis, including work by KPMG, highlights a clear direction of travel. Demand for lower-impact building materials is growing as policy, cost structures and procurement requirements evolve. However, the central challenge is no longer awareness. It is adoption at scale. Despite increasing interest in alternative materials, very few successfully make the transition from innovation into mainstream construction use. 

The barriers are rarely about concept. They are about integration, including cost competitiveness, supply chain readiness, regulatory alignment and the ability to perform within established building practices without adding complexity. 

This is where many material innovations stall. 

What it takes to bring new building materials to market 

Moving from development to deployment requires coordination across the value chain, from manufacturers and developers through to regulators and investors who can support the transition from pilot stage to scaled production. 

It also depends on education and industry engagement to build confidence across supply chains that are often risk-averse and heavily standardised. 

This challenge is particularly clear in materials derived from secondary industrial waste streams. While these materials already exist at scale, bringing them into mainstream construction requires investment in production infrastructure, validation and commercial rollout. 

Innovation alone is not enough for adoption. New building materials must also be commercially viable, cost-competitive and capable of integrating into existing construction practices if they are to succeed at scale. 

This is where companies such as EnviraBoard are working to address a key bottleneck, by developing construction materials from secondary industrial waste streams designed to integrate into existing building systems while meeting the practical demands of the market. 

The broader opportunity is not only in developing new materials, but in enabling their adoption within a construction industry that is structurally evolving but operationally constrained. 

Real progress depends on solutions that are commercially viable, operationally compatible, and ready for large scale deployment, supported by investment and collaboration across the value chain. 

Learn more about EnviraBoard 

The transition to lower-impact construction materials will depend not only on innovation, but on the ability to scale commercially viable solutions. 

EnviraBoard is developing building boards from secondary industrial streams designed for integration into existing construction practices. 

To learn more about our progress and growth plans, visit www.enviraboard.com or register your interest here

FTSE 100 slips after Iran and Israel exchange fire

The FTSE 100 slipped back on Monday after Middle East tensions ratcheted higher over the weekend.

Equities took a step down following reports that Iran fired rockets at Israel for the first time since the April ceasefire in response to Israeli attacks on Lebanon. Despite pressure from Donald Trump not to retaliate, Israel responded with strikes on Iran. 

“Hopes have been dashed for the two key things investors desperately wanted – an end to the Iran war and interest rates not to go up,” says Dan Coatsworth, head of markets at AJ Bell.

“Investors have been on the edge of their seat waiting for a breakthrough in Middle East negotiations. Renewed fighting between Iran and Israel has thrown cold water on the prospect of a resolution any time soon, meaning the focus shifts back to worries about oil supplies and what that means for inflation.

But the markets took the step-up in tensions in stride, with oil inevitably rising but staying below the key $100 level as traders grow sensitised to the conflict and the market impact.

The big issue is whether central banks have to hike rates – but there was only a whisper of this concern on Monday.

“Central banks would normally raise rates to fight inflation, and there have been market expectations for a hike ever since the Iran war began,” Russ Mould said.

“In theory, a sustained inflation shock could hurt the economy and central banks would eventually cut rates to stimulate spending. That could be a story for another day though, particularly as the latest jobs data from the US would suggest the Middle East conflict has yet to cause economic disruption given a strong labour market.”

Given the degree of the escalation over the weekend, an FTSE 100 down 0.3% at the time of writing seems an acceptable result for UK stocks.

The index held above 10,300, with oil stocks and defensive names offsetting losses in UK-centric and interest-rate-sensitive sectors.

Barratt Redrow and Marks and Spencer were among the heaviest hit as investors rotated into BP, Shell and British American Tobacco.

Gattaca: already up 42% in last three months, these shares, now 147.50p, could soon be heading to 175p then 200p 

There are not many quoted companies that expect to almost double profits in the current year, but Gattaca (LON:GATC) is certainly expecting to do so in its year to the end of next month. 
Four weeks ago, the specialist staffing solutions business issued another material upgrade to investors. 
The £47m-capitalised group help science, technology, engineering, and mathematics (STEM) employers solve their workforce challenges through tailored solutions, strategic consultancy, and technology-enabled services.  
Its approach ...

Three investment trusts with yields above 6%

With volatility starting to creep back into the market and valuations globally looking on the rich side, income investors may be seeking allocations that provide yield.

We highlight three investment trusts that could be considered ‘high yield’ trusts with yields above 6%. The selection also offers diversification away from assets that have faced turbulence over the past week.

GCP Infrastructure Investments (LON: GCP)

A FTSE 250 constituent listed since July 2010, GCP Infrastructure is a Jersey-incorporated trust advised by Gravis Capital Management. Its objective is to generate regular, sustained long-term distributions and preserve capital by lending primarily into UK infrastructure projects with long-dated, public-sector-backed, availability-based revenues. Many of them are structured to benefit from partial inflation protection.

At 31 March 2026, the portfolio comprised 47 investments, a weighted average annualised yield of 8.0%, an average life of 11 years and 49.4% partially inflation-protected.

The current 22% discount to NAV means the trust yields 9.1%, backed by cash flows from UK infrastructure projects, including a Birmingham biomass plant, Nottingham Police buildings, and schools in Slough.

By sector, it is weighted towards renewables (57%), public–private partnerships (28%) and supported social housing (15%), with its largest single exposure the cross-collateralised Cardale PFI loan at 14.6% of assets.

NAV stood at £828.9 million, or 100.26p per share, essentially flat over the quarter as a 0.57p uplift from higher near-term power-price forecasts and a 0.26p boost from share buybacks offset reductions tied to lower OBR inflation forecasts and project-specific updates.

For investors, the headline attraction is the yield. The 7.00p dividend equates to a 9.1% yield and a payout that has been maintained at 1.75p on a quarterly basis since 2021.

The main risk here is sentiment towards the UK. But one could argue this has already been priced into the current discount.

Dunedin Income Growth (LON: DIG)

One of the oldest investment trusts in existence, with roots stretching back to 1873, Dunedin Income Growth is an Aberdeen-managed UK equity income vehicle run by Ben Ritchie and Rebecca Maclean and benchmarked against the FTSE All-Share.

It aims to grow both income and capital from a high-quality portfolio invested mainly in UK-listed companies or businesses with significant UK operations or exposure.

On 30 April 2026, the trust held 36 investments, yet its top 20 accounted for just under 69% of the portfolio, with an eye-catching selection of stocks you won’t find in other UK equity income funds, as well as income-bearing heavyweights.

The sector mix is diversified: financials lead at 25.6%, followed by technology (15.8%), industrials (13.8%), energy (10.9%), healthcare (9.4%), consumer discretionary (7.2%), consumer staples (5.8%), utilities (5.6%) and real estate (5.2%), with a sliver of cash. Crucially, that diversity extends to where the income comes from, the trust is not simply clustered in the usual high-yield staples.

The holdings themselves span the market-cap spectrum. Large-cap dividend holdings such as TotalEnergies (7.6%, the single largest position), RELX, NatWest, the London Stock Exchange Group, Standard Chartered, National Grid, AstraZeneca, Tesco and Diageo sit alongside a deliberate emphasis on quality mid-caps and compounders; Softcat, Oxford Instruments, Sage, Experian, Sirius Real Estate, LondonMetric, Convatec and French LNG specialist Gaztransport among them.

A recent dip in trust’s shares means it now yields 6.3%. Of the three outlined here, it is the most exposed to equity markets, and investors can make their own judgment whether this presents a risk in the current environment.

EJF Investments (LON: EJFI)

The most specialist of the three investment trusts and another quarterly dividend payer, EJF Investments, is a constituent of the Specialist Fund Segment and managed by US-based EJF Capital LP, a group with around $5.4 billion under management.

EJFI offers exposure to debt issued by smaller US banks and insurance companies – something that makes this trust stand out from other higher-income investment trusts.

US banks provide a stable source of income for investors and those looking to build a truly diversified portfolio won’t find anything else like EFJ listed in London.

At 31 March 2026, securitisations and related investments accounted for roughly 69.5% of group assets, with CDO equity tranches alone accounting for about 62%; credit risk transfer positions and US bank debt added a further 6.4% and 4.4%, respectively, with the balance in cash and a money-market fund.

Since 2017, the trust has had negative yearly NAV performance only twice.

But the main attraction is, of course, the progressive dividend. The trust raised the quarterly dividend by 7% to an annualised 11.45p, a yield of roughly 9% on the share price.

The shares traded at a 23% discount at quarter-end (narrowing to 21.9% by end-April), and management alignment is strong, with EJF owning around 28% of the shares and the board holding authority to tender up to 5% of the stock annually.

Some may see risks in gearing (a gearing ratio of about 26.5%, covered 3.39 times) and concentration in the fortunes of small US financial institutions. But this concentration is a result of expertise in the sector.

Ingredion to buy Tate & Lyle for £2.7bn in cash takeover

Another former FTSE 100 blue chip is leaving London’s markets. Tate & Lyle has agreed to a recommended cash takeover by US ingredients group Ingredion, valuing the speciality food and beverage business at around £2.7 billion, or roughly £2.8 billion once permitted dividends are included.

Shareholders will receive 595p in cash per share, plus a final dividend of up to 13.2 pence for the year to March 2026 and an interim dividend of up to 6.8 pence for the following half-year.

The total offer of up to 615p a share represents a premium of about 64% to Tate & Lyle’s undisturbed closing price on 13 May, and roughly 71% to its three-month average.

The deal values Tate & Lyle at an enterprise value of £3.8 billion.

Tate & Lyle’s directors, advised by Goldman Sachs and Greenhill, intend to recommend it unanimously. They hold about 17.1% of the shares.

The deal doesn’t look opportunist; there have been issues at Tate & Lyle for some time.

Tate & Lyle has spent the past few years reshaping itself, selling its lower-margin Primient commodity business in the Americas and buying speciality gums and pectin maker CP Kelco in late 2024. The aim was to pivot towards healthier, higher-growth ingredients, building expertise in reducing sugar, calories and fat while adding fibre and protein.

By last July, the group had set out a medium-term plan targeting 4-6% organic revenue growth, with earnings outpacing both EBITDA and revenue.

But Consumer sentiment has softened across major regions over the past year, and Tate & Lyle, like several peers, trimmed its guidance. The year to March 2026 brought a 3% fall in both revenue and pro forma adjusted EBITDA, in line with the lowered expectations flagged the previous October.

Why US tech shares sank last week

The NASDAQ closed down nearly 4% on Friday, its worst daily performance in about 8 months, as trades hit the sell button on swathes of technology and AI-related shares.

Chipmakers and memory stocks were the biggest detractors, with names such as Micron and Nvidia driving the index lower. Micron has been one of the standout performers of 2026 as investors piled into the memory chip maker and its valuations surpassed $1 trillion. Nvidia has become the undisputed AI champion with a market cap that has exceeded $5 trillion and there are plenty of investors who won’t need asking twice to book gains.

But it wasn’t just Micron and Nvidia that tumbled. Neoclouds such as Nebius and CoreWeave plummeted, as did more established names like AMD and Intel.

Broadcom outlook spooks market

Last week, Broadcom spooked the market with a lacklustre earnings outlook. Despite comfortably beating estimates for its second quarter results, investors wanted more in terms of future earnings projections. The reaction in Broadcom’s shares – a 15% premarket decline – underscores the sky-high expectations investors have of AI-related firms, but also how quickly and severely the market is prepared to punish stocks that show any signs of weakness. 

SpaceX IPO seen as a top

Investors are also looking for signs of exuberance to call a market top, and SpaceX’s $1.75 trillion IPO fits the bill. The company generated just below $20 billion in revenue in 2025, putting it on an eye-watering price-to-sales ratio that makes a mockery of traditional valuation methodologies.

Even though Morgan Stanley predicts SpaceX will generate $3.4 trillion in revenue by 2040, the IPO valuation has all the signs of a frenzy and traders getting ahead of themselves, which sometimes happens at a market peak.

SpaceX IPO sparks rotation 

Elon Musk’s SpaceX is seeking to raise at least $75 billion in its IPO. This money has to come from somewhere. 

There is a school of thought that the tech sell-off last week was, in part, driven by investors rebalancing their portfolios to free up cash to allocate to SpaceX. A logical source of this cash is the AI-related tech shares that have soared since OpenAI launched ChatGPT in November 2022. These are the names that were hit the hardest last week, sending the market into a tailspin.

AIM weekly movers: Marechale Capital’s triple acquisition

11

Corporate finance business Marechale Capital (LON: MAC) is acquiring broker Stanford Capital Partners along with global asset tokenisation platform Blubird Global and NJC Capital Management VSA Private Fund and its manager. The payment is 75.2 million shares issued at 1.75p each, which values the businesses at £1.32m. There will be £1.06m raised at the same price. This will make Marechale a digital merchant bank with tokenisation offering an alternative way of raising money for clients. The share price soared 123% to 4.45p.

Bacchus Capital proposes to make a £3.5m strategic investment in Beowulf Mining (LON: BEM) as part of a £4m fundraising. The cash would fund progress with the Kallak iron ore project in Sweden and prospects in Finland until 2027. The share price recovered 63.6% to 9p.

Forestry investor Woodland Capital has increased its stake in energy and critical minerals business Focus Xplore (LON: FOX) from 4.4% to 6.5%. The share price increased 36.4% to 0.0375p.

Drinks brands owner Distil (LON: DIS) says Ardgowan Distillery Company has agreed to the early conversion of £3m of convertible loan notes issued in July 2021. This will give Distil a 10.5% stake. It will also receive a payment of £395,000. The Distil share price rebounded 35.8% to 0.055p.

FALLERS

Portmeirion (LON: PMP) announced a fundraising late on Wednesday evening. It raised £15m at 50p/share and a retail offer could raise up to £2m more. The homeware brands company will use the cash to reduce net debt and to invest in the US Amazon online business that has been brought in-house. There could also be small bolt-on acquisitions. The share price slumped 43.5% to 54p.

Litigation Capital Management (LON: LIT) says that the debt covenant waiver by Northleaf has been extended to the end of June. The interest charge remains two percentage points higher during the waiver. Two cases with A$9m invested have had negative developments and this will lead to write-downs. The strategic review continues. The share price declined 37.5% to 2.6p.

Dotlines Global (LON: DOTL) fell 29.2% to 8.5p during the week. The Singapore-based technology company moved from the Main Market on 11 May when the business reversed into shell Ikigai Ventures. The deal was done at 9.5p/share.

CleanTech Lithium (LON: CTL) has raised £4.77m via a placing at 6p/share. A proposed WRAP retail offer could raise up to £250,00. The outstanding convertible loan notes will be converted into 64.5 million shares. Chairman Steve Kesler has taken £276,273 of fees in 4.6 million shares at the issue price. The cash raised will fund licence purchase costs at Laguna Verde, finance the environmental impact assessment and refinement of the direct lithium extraction processes. Nearly 20 million options will be granted to directors and senior management as part of an incentivisation package. The share price dipped 26.2% to 5.9p.